According to IMARC Group’s latest report, titled “Extracorporeal Membrane Oxygenation Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global extracorporeal membrane oxygenation machine market is expected to exhibit a CAGR of 5.3% during 2022-2027. Looking forward, IMARC Group expects the global extracorporeal membrane oxygenation machine market to continue its robust growth during the forecast period (2022-2027).

Extracorporeal membrane oxygenation (ECMO) machine is a life support equipment that oxygenates red blood cells (RBCs) of patients suffering from prolonged cardiac and respiratory problems. It is extensively used when the heart and lungs cannot provide an adequate amount of gas exchange or perfusion that sustains life. The machine pumps out the blood to remove the carbon dioxide and sends back rewarmed, oxygen-filled blood back into the body. ECMO machine is usually applied in critical care situations to allow blood to bypass the heart and lungs, enabling the organs to rest and heal.

Request For a Free PDF Sample Report: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market/requestsample

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

Extracorporeal Membrane Oxygenation Machine Market Trends:

The global extracorporeal membrane oxygenation machine market is primarily driven by the increasing prevalence of respiratory infections and cardiovascular diseases and strokes. The rising awareness among individuals about the benefits of ECMO machines has also escalated its demand globally. Besides this, these machines are increasingly being used for patients who are more susceptible to chronic medical ailments like coronavirus disease (COVID-19) and acute respiratory distress syndrome (ARDS). Furthermore, the rising number of tobacco smokers, the growing geriatric population and the newborns suffering from respiratory diseases due to congenital disabilities and trauma are some of the other factors that are significantly influencing the market growth.

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

  • Abbott Laboratories
  • ALung Technologies Inc.
  • Braile Biomedical
  • Eurosets, LivaNova PLC
  • Medtronic
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Origen Biomedical, Inc.
  • Terumo Corporation
  • Xenios AG.

Key Market Segmentation:

The report has categorized the market based on component, modality, patient type and application.

Breakup by Component:

  • Pumps
  • Oxygenator
  • Controllers
  • Cannula
  • Accessories

Breakup by Modality:

  • Veno-Arterial
  • Veno-Venous
  • Arterio-Venous

Breakup by Patient Type:

  • Neonates
  • Pediatric
  • Adult

Breakup by Application:

  • Respiratory
  • Cardiac
  • ECPR

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Explore full report with TOC & List of Figures: https://bit.ly/3W751bO

Key highlights of the report:                                                    

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St.

Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800